These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Afatinib and Temozolomide combination inhibits tumorigenesis by targeting EGFRvIII-cMet signaling in glioblastoma cells. Vengoji R; Macha MA; Nimmakayala RK; Rachagani S; Siddiqui JA; Mallya K; Gorantla S; Jain M; Ponnusamy MP; Batra SK; Shonka N J Exp Clin Cancer Res; 2019 Jun; 38(1):266. PubMed ID: 31215502 [TBL] [Abstract][Full Text] [Related]
5. Engagement of cellular prion protein with the co-chaperone Hsp70/90 organizing protein regulates the proliferation of glioblastoma stem-like cells. Iglesia RP; Prado MB; Cruz L; Martins VR; Santos TG; Lopes MH Stem Cell Res Ther; 2017 Apr; 8(1):76. PubMed ID: 28412969 [TBL] [Abstract][Full Text] [Related]
6. Mechanisms and Antitumor Activity of a Binary EGFR/DNA-Targeting Strategy Overcomes Resistance of Glioblastoma Stem Cells to Temozolomide. Sharifi Z; Abdulkarim B; Meehan B; Rak J; Daniel P; Schmitt J; Lauzon N; Eppert K; Duncan HM; Petrecca K; Guiot MC; Jean-Claude B; Sabri S Clin Cancer Res; 2019 Dec; 25(24):7594-7608. PubMed ID: 31540977 [TBL] [Abstract][Full Text] [Related]
7. Crosstalk between the urokinase-type plasminogen activator receptor and EGF receptor variant III supports survival and growth of glioblastoma cells. Hu J; Jo M; Cavenee WK; Furnari F; VandenBerg SR; Gonias SL Proc Natl Acad Sci U S A; 2011 Sep; 108(38):15984-9. PubMed ID: 21896743 [TBL] [Abstract][Full Text] [Related]
8. Differentiation of glioblastoma multiforme stem-like cells leads to downregulation of EGFR and EGFRvIII and decreased tumorigenic and stem-like cell potential. Stockhausen MT; Kristoffersen K; Stobbe L; Poulsen HS Cancer Biol Ther; 2014 Feb; 15(2):216-24. PubMed ID: 24525857 [TBL] [Abstract][Full Text] [Related]
9. Cross-talk between PARN and EGFR-STAT3 Signaling Facilitates Self-Renewal and Proliferation of Glioblastoma Stem Cells. Yin J; Seo Y; Rhim J; Jin X; Kim TH; Kim SS; Hong JH; Gwak HS; Yoo H; Park JB; Kim JH Cancer Res; 2023 Nov; 83(22):3693-3709. PubMed ID: 37747775 [TBL] [Abstract][Full Text] [Related]
10. Xihuang Pill-destabilized CD133/EGFR/Akt/mTOR cascade reduces stemness enrichment of glioblastoma via the down-regulation of SOX2. Xu L; Duan H; Zou Y; Wang J; Liu H; Wang W; Zhu X; Chen J; Zhu C; Yin Z; Zhao X; Wang Q Phytomedicine; 2023 Jun; 114():154764. PubMed ID: 36963368 [TBL] [Abstract][Full Text] [Related]
11. Glioma Stem Cell-Specific Superenhancer Promotes Polyunsaturated Fatty-Acid Synthesis to Support EGFR Signaling. Gimple RC; Kidwell RL; Kim LJY; Sun T; Gromovsky AD; Wu Q; Wolf M; Lv D; Bhargava S; Jiang L; Prager BC; Wang X; Ye Q; Zhu Z; Zhang G; Dong Z; Zhao L; Lee D; Bi J; Sloan AE; Mischel PS; Brown JM; Cang H; Huan T; Mack SC; Xie Q; Rich JN Cancer Discov; 2019 Sep; 9(9):1248-1267. PubMed ID: 31201181 [TBL] [Abstract][Full Text] [Related]
12. PARK7 maintains the stemness of glioblastoma stem cells by stabilizing epidermal growth factor receptor variant III. Kim JY; Kim HJ; Jung CW; Choi BI; Lee DH; Park MJ Oncogene; 2021 Jan; 40(3):508-521. PubMed ID: 33188296 [TBL] [Abstract][Full Text] [Related]
14. ANO1 regulates the maintenance of stemness in glioblastoma stem cells by stabilizing EGFRvIII. Kim HJ; Kim JY; Jung CW; Lee YS; An JY; Kim EH; Kim KH; Lee SP; Park JY; Park MJ Oncogene; 2021 Feb; 40(8):1490-1502. PubMed ID: 33452454 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of EGFR induces a c-MET-driven stem cell population in glioblastoma. Jun HJ; Bronson RT; Charest A Stem Cells; 2014 Feb; 32(2):338-48. PubMed ID: 24115218 [TBL] [Abstract][Full Text] [Related]
16. FAM129A promotes self-renewal and maintains invasive status via stabilizing the Notch intracellular domain in glioma stem cells. Liu G; Zhang P; Chen S; Chen Z; Qiu Y; Peng P; Huang W; Cheng F; Zhang Y; Li H; Xiao Q; Mao F; Wang B; Jiang X; Wan F; Guo D; Yu X Neuro Oncol; 2023 Oct; 25(10):1788-1801. PubMed ID: 37083136 [TBL] [Abstract][Full Text] [Related]
17. Activation of multiple ERBB family receptors mediates glioblastoma cancer stem-like cell resistance to EGFR-targeted inhibition. Clark PA; Iida M; Treisman DM; Kalluri H; Ezhilan S; Zorniak M; Wheeler DL; Kuo JS Neoplasia; 2012 May; 14(5):420-8. PubMed ID: 22745588 [TBL] [Abstract][Full Text] [Related]
18. E3 ubiquitin-ligase RNF138 may regulate p53 protein expression to regulate the self-renewal and tumorigenicity of glioma stem cells. Chao Q; Li X; Huang Y J Cancer Res Ther; 2023 Dec; 19(6):1636-1645. PubMed ID: 38156932 [TBL] [Abstract][Full Text] [Related]
19. CircKPNB1 mediates a positive feedback loop and promotes the malignant phenotypes of GSCs via TNF-α/NF-κB signaling. Jiang Y; Zhao J; Liu Y; Hu J; Gao L; Wang H; Cui D Cell Death Dis; 2022 Aug; 13(8):697. PubMed ID: 35945192 [TBL] [Abstract][Full Text] [Related]
20. Nuclear EGFRvIII-STAT5b complex contributes to glioblastoma cell survival by direct activation of the Bcl-XL promoter. Latha K; Li M; Chumbalkar V; Gururaj A; Hwang Y; Dakeng S; Sawaya R; Aldape K; Cavenee WK; Bogler O; Furnari FB Int J Cancer; 2013 Feb; 132(3):509-20. PubMed ID: 22729867 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]